The place of molecular modelling in drug design is now firmly established. This book contains chapters from young scientists in industry and academia. They present many of the new methods available as well as describing the correct use of more established techniques. The book attempts to combine optimism, including methods designed to semi-automate a large part of the drug design process, with pragmatism, pointing out some of the traps into which the unwary researcher may be drawn.